Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S29 pseudogene 21 (RPS29P21) is classified as a processed pseudogene of the ribosomal protein S29 gene family in the human genome[11][9][12]. Unlike the functional ribosomal protein S29 gene, which encodes a structural component of the small ribosomal (40S) subunit, pseudogenes such as RPS29P21 do not produce functional protein products[3][11]. Their sequence is related to the parental gene but they lack biological activity and are not known to participate in cellular or disease processes. There is no current evidence that RPS29P21 is involved in therapeutic targeting, disease association, or biomarker applications.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S29 pseudogene 21 (RPS29P21).